{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:44:33Z","timestamp":1785350673537,"version":"3.55.0"},"reference-count":24,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1507\/endocrj.k05-121","type":"journal-article","created":{"date-parts":[[2006,8,30]],"date-time":"2006-08-30T05:40:03Z","timestamp":1156916403000},"page":"467-472","source":"Crossref","is-referenced-by-count":36,"title":["TSH Receptor Antibody Measurements and Prediction of Remission in Graves' Disease Patients Treated with Minimum Maintenance Doses of Antithyroid Drugs"],"prefix":"10.1507","volume":"53","author":[{"given":"Yasuyuki","family":"OKAMOTO","sequence":"first","affiliation":[{"name":"Sumire Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syun-ichi","family":"TANIGAWA","sequence":"additional","affiliation":[{"name":"Yamasa Corporation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"ISHIKAWA","sequence":"additional","affiliation":[{"name":"Cosmic Corporation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"HAMADA","sequence":"additional","affiliation":[{"name":"Sumire Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Notsu K, Oka N, Masaki Y, Furuya H, Kato Y (1991) Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs. J Clin Endocrinol Metab 73: 396-400.","DOI":"10.1210\/jcem-73-2-396"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Schleusener H, Schwander J, Fischer C, Holle R, Holl G, Badenhoop K, Hensen J, Finke R, Bogner U, Mayr WR (1989) Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 120: 689-701.","DOI":"10.1530\/acta.0.1200689"},{"issue":"6","key":"3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1507\/endocrj1954.38.683","volume":"38","author":"TAJIRI J","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0013-7219","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Talbot JN, Duron F, Feron R, Aubert P, Milhaud G (1989) Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year. J Endocrinol Inves 12: 589-595.","DOI":"10.1007\/BF03350008"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takasu N, Akamine H, Komiya I, Yamada T (1995) Simple and reliable method for predicting the remission of Graves' disease: revised triiodothyronine-suppression test, indexed by serum thyroxine. J Endocrinol Invest 18: 288-294.","DOI":"10.1007\/BF03347815"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zingrillo M, D'Aloiso L, Ghiggi MR, Di Cerbo A, Chiodini I, Torlontano M, Liuzzi A (1996) Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence? Clin Endocrinol (Oxf) 45: 201-206.","DOI":"10.1046\/j.1365-2265.1996.d01-1563.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Varsamidis K, Varsamidou E, Mavropoulos G (2000) Doppler ultrasonography in predicting relapse of hyperthyroidism in Graves' disease. Acta Radiol 41: 45-48.","DOI":"10.1258\/rsmacta.41.1.45"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Prakash R (1996) Prediction of remission in Graves' disease treated with long-term carbimazole therapy: evaluation of technetium-99m thyroid uptake and TSH concentrations as prognostic indicators. Eur J Nucl Med 23: 118-122.","DOI":"10.1007\/BF01731833"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.1.98"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1210\/er.19.6.673"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.1.90"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1089\/1050725042451248"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(00)00385-5"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01197.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wallaschofski H, Miehle K, Mayer A, Tuschy U, Hentschel B, Paschke R (2002) Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment. Horm Metab Res 34: 383-388.","DOI":"10.1055\/s-2002-33470"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-814217"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1460173"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wartofsky L, Glinoer D, Solomon B, Lagasse R (1991) Differences and similarities in the treatment of diffuse goiter in Europe and the United States. Thyroid 1: 129-135.","DOI":"10.1089\/thy.1991.1.129"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Glinoer D, Hesch D, Lagasse R, Laurberg P (1987) The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey. Acta Endocrinol (Cepenh) 185 (Suppl): 9-37.","DOI":"10.1530\/acta.0.115S006"},{"issue":"2","key":"20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1507\/endocrj1954.36.299","volume":"36","author":"NAGAYAMA Y","year":"1989","ISSN":"https:\/\/id.crossref.org\/issn\/0013-7219","issn-type":"print"},{"issue":"4","key":"21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1507\/endocrj.44.553","volume":"44","author":"MASHIO Y","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/0918-8959","issn-type":"print"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.50.45"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sanders J, Oda Y, Roberts S, Kiddie A, Richards T, Bolton J, McGrath V, Walters S, Jaskolski D, Furmaniak J, Smith BR (1999) The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor. J Clin Endocrinol Metab 84: 3797-3802.","DOI":"10.1210\/jcem.84.10.6071"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.50.113"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/53\/4\/53_4_467\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:42:44Z","timestamp":1618296164000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/53\/4\/53_4_467\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k05-121","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}